• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Vaccine Safety Expert Shares 5 COVID-19 Vaccine Facts to Protect 2021

by Dr. Noam Tau of Sheba Medical Center 12/17/2020 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Vaccine Safety Expert Shares 5 COVID-19 Vaccine Facts to Protect
Dr. Noam Tau of Sheba Medical Center

Now more than ever, public confidence is key. It’s our job as medical professionals, the FDA’s job, and public figures’ job to convince the population to vaccinate by presenting the real results of studies.

The current vaccine hesitancy, which might result in a large proportion of people refusing vaccination, will leave us with an ongoing global crisis, even with the best vaccines ever made. A vaccine only works if it is actually administered.

Five Vaccine Facts to Protect 2021:

1. Although Pfizer and Moderna’s COVID-19 vaccines utilize a technology not used in vaccines before, it is in no way new. Studies on this type of vaccine have been conducted for the last 10 years, and even earlier.

2. The approval studies conducted by Pfizer and Moderna included more than 70,000 participants in both, compared to 4,000 participants in a “regular” vaccine trial.

3. The FDA did not allow any shortcuts in the approval process. The main thing that sped up the proceedings was faster and more efficient bureaucracy and obtaining funding.

4. Now that the Pfizer vaccine has received an FDA emergency use authorization, hundreds of thousands of people have already been vaccinated, with a remarkable safety profile.

5. In vaccines, if side effects do appear, they mostly do so in the first 28 days. The studies by Pfizer and Moderna followed patients for more than 2 months and found that the vast majority of side effects were mild and short-lived.


About Dr. Noam Tau

Sheba Medical Center’s Dr. Noam Tau was the lead researcher of a recent study assessing the safety of all U.S.-approved vaccines over a twenty-year period. Dr. Tau’s study reviewed 57 FDA approved vaccines between 1996-2015, showing that an overwhelming majority were safe to use on a large scale. 


  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Coronavirus (COVID-19)

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

2026 Predictions & Trends

Healthcare 2026 Forecast: Executives on AI Survival, Financial Reckoning, and the End of Point Solutions

2026 Healthcare Executive Predictions: Why the AI “Pilot Era” Is Officially Over

Most-Read

HHS Launches 'OneHHS' AI Strategy to Integrate AI Across CDC, CMS, and FDA for Efficiency and Public Trust

HHS Launches ‘OneHHS’ AI Strategy to Integrate AI Across CDC, CMS, and FDA for Efficiency and Public Trust

Kristen Hartsell, VP of Clinical Services, RedSail Technologies

The Pharmacy Closures Crisis: How Independent Pharmacies Are Fixing Pharmacy Deserts

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

The VBC Paradox: Why Hospitals Are Doubling Down on Value-Based Care While Revenue at Risk Lags

The VBC Paradox: Why Hospitals Are Doubling Down on Value-Based Care While Revenue at Risk Lags

Tebra Secures $250M to Challenge Legacy EHRs with AI-Powered Automation

Tebra Secures $250M to Challenge Legacy EHRs with AI-Powered Automation

AstraZeneca Selects Salesforce Agentforce Life Sciences to Deploy AI-Powered Global Customer Engagement

AstraZeneca Selects Salesforce Agentforce Life Sciences to Deploy AI-Powered Global Customer Engagement

Aidoc Partners with NVIDIA MONAI to Scale Open-Source Clinical AI

Aidoc Partners with NVIDIA MONAI to Scale Open-Source Clinical AI

RapidAI Secures FDA Clearance for Five New Deep Clinical AI Modules, Expanding Enterprise Imaging Platform

RapidAI and AWS Deepen Partnership to Scale Clinical AI in Healthcare

Greece and Sword Health to Build AI-Powered Healthcare Front Door

Greece and Sword Health to Build AI-Powered Healthcare Front Door

GE HealthCare Acquires Intelerad for $2.3B to Create Cloud-First, AI-Enabled Imaging Ecosystem

GE HealthCare Acquires Intelerad for $2.3B to Create Cloud-First, AI-Enabled Imaging Ecosystem

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |